
|Videos|January 12, 2022
Urology Times 50 Innovations Series: Testosterone therapy
Author(s)Urology Times staff
"This field has exploded!" says Mohit Khera, MD, MBA, MPH.
Advertisement
As part of the Urology Times' 50th Anniversary Innovation Celebration, Amy Pearlman, MD, interviewed Mohit Khera, MD, MBA, MPH, on how testosterone therapy has greatly impacted the field of urology over the past 50 years. Khera is a professor of urology and director of the Laboratory for Andrology Research, and director of the Executive Health Program at the McNair Medical Institute at Baylor College of Medicine in Houston, Texas. Pearlman is a clinical assistant professor of urology and the director of the Men’s Health Program at the Carver College of Medicine at University of Iowa Health Care in Iowa City, Iowa.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Unmet needs and emerging solutions in MRI-guided prostate cancer care
2
HHS requests testosterone therapy label updates, citing new safety data
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5
















































